Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
121M
-
Shares change
-
+16.4M
-
Total reported value, excl. options
-
$948M
-
Value change
-
+$129M
-
Put/Call ratio
-
12.43
-
Number of buys
-
95
-
Number of sells
-
-54
-
Price
-
$7.82
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2024
181 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q4 2024.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121M shares
of 148M outstanding shares and own 81.73% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (16.5M shares), RA CAPITAL MANAGEMENT, L.P. (14.2M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (10.2M shares), BlackRock, Inc. (7.89M shares), RTW INVESTMENTS, LP (7.48M shares), Deep Track Capital, LP (6.48M shares), VANGUARD GROUP INC (5.69M shares), CITADEL ADVISORS LLC (4.73M shares), BVF INC/IL (4.33M shares), and Avoro Capital Advisors LLC (4.1M shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.